INSIGHTS ON QUALITY ASSURANCE
-
US GMP (21 CFR 820) Manufactured Oligos For Preclinical Research
Learn why Custom cGMP Oligos should be considered to ensure oligo products meet the strict standards of MDx, LDTs, and preclinical research.
-
Navigating GxP Compliance Challenges
Learn how to select and manage trusted software suppliers to streamline your digital transformation, mitigate risks, and ensure regulatory adherence. Watch to discover best practices and real-world examples.
-
Digital Transformation Essentials: Building A Strong Data Foundation
In this presentation we discuss the importance of embracing digital solutions, the paradigm shift toward finding data solutions, and the terminology used by digital transformation leaders.
-
Eliminating Analytical Bottlenecks And Streamlining Drug Discovery
Advanced analytical methods play a crucial role in drug development pipelines by providing accurate data for informed decision-making. However, the increasing complexity and volume of data present challenges in managing and analyzing it effectively.
-
Developing Effective Procedures10/21/2024
Effective procedure development starts with understanding the purpose and should integrate change management, risk management, and knowledge management to ensure a robust quality system.
-
The Power And Potential Of RBM In Clinical Trials11/8/2023
Risk-based monitoring increases overall trial oversight by balancing “must-do” data collection and “nice-to-have” data against site and patient burden — and, more importantly, patient safety.
-
Key Takeaways From The ISPE Ireland Annex 1 Event4/12/2024
Key insights from the ISPE Ireland Annex 1 Event shed light on challenges and solutions in meeting EU GMP guidelines for sterile medicinal products.
-
The Future Of Compliance, Efficiency, And Data Integrity5/5/2025
Explore how eValidation revolutionizes the pharmaceutical industry by enhancing compliance, efficiency, and data integrity, as well as its indispensable role in modernizing traditional validation methods.
-
Innovative Strategies For Residual DNA And Viral Titre Quantitation5/22/2025
Discover how digital PCR improves the accuracy of residual host cell DNA and viral titre quantification in biotherapeutic manufacturing to enhance product quality, safety, and regulatory compliance.
QUALITY ASSURANCE SOLUTIONS
-
Ditch the spreadsheets, and dive into efficiency. Seamlessly integrate QbD principles and risk management practices into your pharmaceutical development process.
-
Many Life Sciences companies struggle to minimize downtime, ensure safe operations, and reach tight production schedules while maintaining consistent, quality output in a demanding environment, but you can boost efficiency and reliability through our field-tested methodologies.
-
ValGenesis VLMS: The Industry-Leading Platform For Digital CQV
-
Proactively manage risks of pharmaceuticals, medical devices and other products with TrackWise Digital. The built-in templates comply with ISO 14971 and ICH Q9 allowing manufacturers to manage risks throughout the entire product lifecycle directly within TrackWise Digital.
-
Equipped with a diverse array of scales, our seasoned experts possess the finesse and acumen necessary to tackle even the most intricate and potent API projects.